NPPA to issue show-cause notice to Intas, Mankind Pharma for selling diabetes drug sans approval MD Bureau2 Jan 2021 11:26 AM GMTNew Delhi: Coming down on Mankind Pharma and Intas Pharmaceuticals, the National Pharmaceutical Pricing Authority (NPPA) has decided to issue...
Intas Pharma launches immuno booster add on drug to standard Covid treatment Ruchika Sharma12 Nov 2020 5:45 AM GMTThymoquinone has been developed as a stable, standardized and ready-to-use tablet by Intas for the first time in the world.
Intas Pharma COVID-19 specific Hyperimmune Globulin gets DCGI nod to conduct clinical trial Ruchika Sharma30 Aug 2020 5:00 AM GMTIntas is among the world's first to adopt this approach for treating COVID-19 patients. This will be a Corporate Social Responsibility (CSR)...
NPPA fixes retail prices of 30 formulations, defers Sun Pharma, Micro Labs new drug applications Farhat Nasim23 Aug 2020 7:13 AM GMTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India has fixed prices of 30...
Ascent backed-Naari buys 10 ANDAs from Intas Pharma Farhat Nasim12 Jun 2020 9:37 AM GMTThe portfolio acquired comprises eight U.S. FDA approved ANDAs and two products pending approval. It includes generic products in female hormones...
Drug Alert: CDSCO Flags 25 Drugs As Not Of Standard Quality Farhat Nasim11 Jun 2020 8:23 AM GMTThis came after analysis and test conducted by the CDSCO, Drugs Control Departments, on 477 drug samples. Out of this, 452 samples were found of...
